Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dentsply Sirona (XRAY) Shares Outstanding (Diluted Average) (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Shares Outstanding (Diluted Average) for 17 consecutive years, with $199.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 1.87% year-over-year to $199.4 million, compared with a TTM value of $199.4 million through Dec 2025, down 1.87%, and an annual FY2025 reading of $199.4 million, down 1.87% over the prior year.
  • Shares Outstanding (Diluted Average) was $199.4 million for Q4 2025 at Dentsply Sirona, roughly flat from $199.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $220.8 million in Q2 2021 and bottomed at $199.3 million in Q2 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $210.8 million, with a median of $212.9 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) grew 0.5% in 2021, then decreased 5.5% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $220.2 million in 2021, then decreased by 2.13% to $215.5 million in 2022, then dropped by 1.62% to $212.0 million in 2023, then decreased by 4.15% to $203.2 million in 2024, then fell by 1.87% to $199.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for XRAY at $199.4 million in Q4 2025, $199.5 million in Q3 2025, and $199.3 million in Q2 2025.